These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 21084518

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage.
    Nowicka-Sans B, Protack T, Lin Z, Li Z, Zhang S, Sun Y, Samanta H, Terry B, Liu Z, Chen Y, Sin N, Sit SY, Swidorski JJ, Chen J, Venables BL, Healy M, Meanwell NA, Cockett M, Hanumegowda U, Regueiro-Ren A, Krystal M, Dicker IB.
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3956-69. PubMed ID: 27090171
    [Abstract] [Full Text] [Related]

  • 6. Resistance to Second-Generation HIV-1 Maturation Inhibitors.
    Urano E, Timilsina U, Kaplan JA, Ablan S, Ghimire D, Pham P, Kuruppu N, Mandt R, Durell SR, Nitz TJ, Martin DE, Wild CT, Gaur R, Freed EO.
    J Virol; 2019 Mar 15; 93(6):. PubMed ID: 30567982
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor.
    Seclén E, González Mdel M, Corral A, de Mendoza C, Soriano V, Poveda E.
    AIDS; 2010 Jan 28; 24(3):467-9. PubMed ID: 19996935
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1.
    Dang Z, Ho P, Zhu L, Qian K, Lee KH, Huang L, Chen CH.
    J Med Chem; 2013 Mar 14; 56(5):2029-37. PubMed ID: 23379607
    [Abstract] [Full Text] [Related]

  • 11. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
    Urano E, Ablan SD, Mandt R, Pauly GT, Sigano DM, Schneider JP, Martin DE, Nitz TJ, Wild CT, Freed EO.
    Antimicrob Agents Chemother; 2016 Jan 14; 60(1):190-7. PubMed ID: 26482309
    [Abstract] [Full Text] [Related]

  • 12. [Prediction of the efficacy of bevirimat used for the treatment of HIV infection in Russia].
    Kazennova EV, Vasil'ev AV, Bobkova MR.
    Vopr Virusol; 2010 Jan 14; 55(3):37-41. PubMed ID: 20608080
    [Abstract] [Full Text] [Related]

  • 13. Mutations in multiple domains of Gag drive the emergence of in vitro resistance to the phosphonate-containing HIV-1 protease inhibitor GS-8374.
    Stray KM, Callebaut C, Glass B, Tsai L, Xu L, Müller B, Kräusslich HG, Cihlar T.
    J Virol; 2013 Jan 14; 87(1):454-63. PubMed ID: 23097440
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A single G10T polymorphism in HIV-1 subtype C Gag-SP1 regulates sensitivity to maturation inhibitors.
    Ghimire D, Kc Y, Timilsina U, Goel K, Nitz TJ, Wild CT, Gaur R.
    Retrovirology; 2021 Apr 09; 18(1):9. PubMed ID: 33836787
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of an HIV-1 maturation inhibitor on the structure and dynamics of CA-SP1 junction helices in virus-like particles.
    Gupta S, Louis JM, Tycko R.
    Proc Natl Acad Sci U S A; 2020 May 12; 117(19):10286-10293. PubMed ID: 32341150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.